Literature DB >> 29152042

Selective Inhibitors of Phosphodiesterase 4B (PDE-4B) May Provide a Better Treatment for CNS, Metabolic, Autoimmune, and Inflammatory Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2017        PMID: 29152042      PMCID: PMC5683697          DOI: 10.1021/acsmedchemlett.7b00425

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences.

Authors:  Sonia Contreras; Javier Milara; Esteban Morcillo; Julio Cortijo
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 2.  Selective Phosphodiesterase 4B Inhibitors: A Review.

Authors:  Mohammed Afzal Azam; Naga Srinivas Tripuraneni
Journal:  Sci Pharm       Date:  2014-06-10
  2 in total
  1 in total

1.  Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size.

Authors:  Nadezda Lipunova; Anke Wesselius; Kar K Cheng; Frederik-Jan van Schooten; Richard T Bryan; Jean-Baptiste Cazier; Maurice P Zeegers
Journal:  Transl Androl Urol       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.